Short Interest in Biofrontera Inc. (NASDAQ:BFRIW) Declines By 38.1%

Biofrontera Inc. (NASDAQ:BFRIW) saw a significant decline in short interest in the month of June. As of June 15th, there was short interest totaling 4,105 shares, a decline of 38.1% from the May 31st total of 6,628 shares. Based on an average daily volume of 1,397 shares, the short-interest ratio is presently 2.9 days.

Biofrontera Stock Performance

BFRIW remained flat at $0.03 on Thursday. 704 shares of the company traded hands, compared to its average volume of 6,009. The stock’s 50 day simple moving average is $0.03 and its 200 day simple moving average is $0.05. Biofrontera has a 52 week low of $0.02 and a 52 week high of $0.28.

Biofrontera Company Profile

Biofrontera AG is a biopharmaceutical company headquartered in Leverkusen, Germany, specializing in the development, manufacture and commercialization of dermatology products. Founded in 1997, the company focuses on therapies for skin diseases through innovative drug and device combinations. Its core business centers on photodynamic therapy, where a photosensitizing agent is activated by a specialized light source to treat precancerous and cancerous skin conditions.

The company’s flagship product, Ameluz, is a topical formulation of aminolevulinic acid used in conjunction with the BF-RhodoLED irradiation device.